Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4200.70 +0.7% SILVER 57.69 +0.9% COPPER 6.60 +0.6% OIL 95.60 −2.4% PALLADIUM 1123.25 −0.5% OMI 0.250 +0.0% BUFF 0.800 +2.6% FEO 0.670 +3.1% LIB 0.730 +1.4% NPR 0.650 +4.8% QZM 0.380 +0.0% BVA 0.750 −1.3% ONAU 0.530 +1.9% FMR 0.225 +0.0% GSVR 0.352 +3.7% PHNM 0.345 +1.5% SLG 5.64 −1.2% CASA 0.065 +8.3% DRY 0.225 +4.7% SOMA 0.570 +1.8% PWRO 0.025 +0.0% GOLD 4200.70 +0.7% SILVER 57.69 +0.9% COPPER 6.60 +0.6% OIL 95.60 −2.4% PALLADIUM 1123.25 −0.5% OMI 0.250 +0.0% BUFF 0.800 +2.6% FEO 0.670 +3.1% LIB 0.730 +1.4% NPR 0.650 +4.8% QZM 0.380 +0.0% BVA 0.750 −1.3% ONAU 0.530 +1.9% FMR 0.225 +0.0% GSVR 0.352 +3.7% PHNM 0.345 +1.5% SLG 5.64 −1.2% CASA 0.065 +8.3% DRY 0.225 +4.7% SOMA 0.570 +1.8% PWRO 0.025 +0.0%
Regulatory

Trulieve Announces Conditional Approval for Texas License

By The Northwire Desk — AI Analysis Dec 03, 2025 · 08:00 TRUL · 8.51 Trulieve Cannabis Corp.
TRUL · Price

Executive Summary

  • Trulieve Cannabis Corp. received conditional approval from the Texas Department of Public Safety for a Dispensing Organization license under the Texas Compassionate Use Program.
  • The license, once fully approved, will allow Trulieve to cultivate, manufacture, and distribute medical cannabis products to patients in Texas.
  • CEO Kim Rivers highlighted the significance of the approval and the company’s intent to expand patient access pending final regulatory clearance.

Key Details

  • Conditional approval granted by the Texas Department of Public Safety for a Dispensing Organization license.
  • License is subject to final approval by the same department.
  • Trulieve TX, Inc. will be authorized to cultivate, manufacture, and distribute high‑quality medical cannabis products in Texas.
  • CEO Kim Rivers statement: “We are excited to be selected for a coveted Texas Dispensing Organization license… Pending necessary approvals, we plan to provide patients compassionate care and expanded access to high quality medical cannabis products.”
  • The approval represents a strategic expansion of Trulieve’s multi‑state operations into the Texas market.

Notable Quotes

“We are excited to be selected for a coveted Texas Dispensing Organization license and we look forward to working with regulators as we complete the licensing process,” – Kim Rivers, CEO, Trulieve
“Pending necessary approvals, we plan to provide patients compassionate care and expanded access to high quality medical cannabis products.” – Kim Rivers, CEO, Trulieve

Read the original news release →

More from Trulieve Cannabis Corp.

Jul 01, 2026 · 08:10

Georgia expansion marks first sales, but revenue compression and margin pressure remain key headwinds.

Production / Operations Jun 09, 2026 · 08:00

Trulieve's $50M Buyback Signals Confidence, But 43% Run-Up Into the Print Caps Near-Term Upside

Other Jun 05, 2026 · 07:00

Trulieve’s NYSE Debut Cements First-Mover Advantage in Post‑Rescheduling U.S. Medical Cannabis, With Texas and Georgia Upside in Focus

Regulatory May 21, 2026 · 08:45

Trulieve Stabilizes Post-Rescheduling Rally as Domestication Vote Looms

Production / Operations May 13, 2026 · 16:30

Trulieve swaps Canadian roots for Delaware law, but the home-run catalyst still awaits a rulemaking hearing.

Other May 07, 2026 · 06:15

Trulieve Posts Profit as Cannabis Rescheduling Lifts Margins

Earnings